Results 101 to 110 of about 35,538 (217)

Recurrent invasive meningococcal infections - quantifying the risk, Germany, 2002 to 2018. [PDF]

open access: yesEuro Surveill, 2020
Krone M, Lâm TT, Claus H, Vogel U.
europepmc   +1 more source

Polyhydroxyalkanoate beads as a particulate vaccine against Streptococcus pneumoniae and Neisseria meningitidis : a thesis presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Microbiology at Massey University, Manawatu, New Zealand [PDF]

open access: yes, 2017
Listed in 2018 Dean's List of Exceptional ThesesStreptococcus pneumoniae and Neisseria meningitidis are the major causes of pneumonia and meningitis, respectively, worldwide.
González Miró, Majela
core  

Serosubtipos de meningococo B causantes de enfermedad invasiva en Cantabria y concordancia con la cepa de la vacuna cubana Meningococcus B serosubtypes causing invasive disease in Cantabria [Spain] and agreement with the Cuban vaccine strain

open access: yesGaceta Sanitaria, 2004
Objetivo: Conocer los serosubtipos de meningococo B causantes de enfermedad invasiva en Cantabria y el porcentaje de concordancia con la cepa de la vacuna cubana VA-Mengoc-BC.
Álvaro González de Aledo, Luis Viloria
doaj  

A systematic review to identify research gaps in studies modeling MenB vaccinations against Neisseria infections.

open access: yesPLoS ONE
The genus Neisseria includes two major human pathogens: N. meningitidis causing bacterial meningitis/septicemia and N. gonorrhoeae causing gonorrhoea.
Soeren Metelmann   +10 more
doaj   +1 more source

Meningoccocal meningitis complicated with subdural effusion: a report of two infant cases

open access: yesJournal of Infection in Developing Countries, 2007
Neisseria meningitidis is a major cause of invasive bacterial infection in children of all ages. Children less than 1 year of age are at greater risk of invasive disease than older children. In endemic countries, the invasive meningococcal infections are
Victor Perez-Pico,1 Eduardo Llausas-Magana,1 Angel Leon-Ramirez,1 Giordano Perez-Gaxiola,2 and Nidia Leon-Sicairos.3
doaj  

4CMenB journey to the 10-year anniversary and beyond

open access: yesHuman Vaccines & Immunotherapeutics
The 4-component meningococcal serogroup B (MenB) vaccine, 4CMenB, the first broadly protective, protein-based MenB vaccine to be licensed, is now registered in more than 50 countries worldwide.
Véronique Abitbol   +10 more
doaj   +1 more source

Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections. [PDF]

open access: yesVirulence, 2019
Muenstermann M   +6 more
europepmc   +1 more source

Overview of Australian Indigenous health status 2014 [PDF]

open access: yes
This Overview of Australian Indigenous health status provides information about: Aboriginal and Torres Strait Islander populations; the context of Indigenous health; various measures of population health status; selected health conditions; and health ...
Australian Indigenous HealthInfoNet
core  

Home - About - Disclaimer - Privacy